IRIS
INDIVERI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.628
Totale 11.628
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.628
Totale 11.628
Salva come PNG Salva come JPEG
Città #
Genova 9.051
Rapallo 1.179
Genoa 872
Vado Ligure 506
Bordighera 20
Totale 11.628
Salva come PNG Salva come JPEG
Nome #
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. 229
Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds. 158
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer 154
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer 152
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells 148
ANTI-TUMOR IMMUNOTHERAPY 143
S-adenosil-L-methionine is able to reverse the immunosuppressive effects of chenodeoxycholic acid in vitro. 142
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 141
AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis 140
The antiphospholipid syndrome: from pathophysiology to treatment 140
Effect of clotting factors concentrates on lymphocyte and neutrophil function in vitro 138
Gene vaccination for the induction of immune tolerance 136
Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. 135
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? 132
Disruption of immunological tolerance: role of AIRE gene in autoimmunity 130
Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. 129
A case of successful pregnancy in a woman with systemic sclerosis treated with cyclosporin. 129
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 128
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. 126
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 126
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway 125
Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens. 122
Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome 122
Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis. 122
In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? 119
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes 119
Fas, Fas ligand, and transfusion immunomodulation 118
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma 117
Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions. 116
A planar support having an ultraflat surface and a device for detecting antigens comprising said planar support 115
Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus 115
Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. 113
Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction 113
Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells. 113
Beyond APECED: An update on the role of the autoimmune regulator gene (AIRE) in physiology and disease 113
Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. 110
sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment. 109
CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity 108
dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. 108
Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. 107
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication 106
Endocrine regulation of suppressor lymphocytes: role of the glucocorticoid-induced TNF-like receptor 106
Autoantibodies to neutrophilic proteases in a case of panniculitis by deficit of alpha1-antitrypsin. 104
Serum HLA class I antigens: markers and modulators of an immune response? 104
DsDNA-specific T-cell lines in systemic lupus erythematosus patients: data suggesting their oligoclonality. 104
Immune homeostasis requires several biologic factors including glucocorticoid hormones 104
Non-antigen specific CD8+ T suppressor lymphocytes. 103
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 103
Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer. 102
Gamma endorphin and HLA class I related immune functions. Preliminary observations. 101
LACTULOSE BREATH TEST IS A NON-INVASIVE TOOL TO ASSESS ESOPHAGEAL INVOLVEMENT IN SCLERODERMA PATIENTS 100
null 99
Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. 99
Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation. 98
CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function. 98
Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. 97
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. 96
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily 96
Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. 96
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. 96
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 96
A case of transposition of the great arteries in a female infant of a HIV-1 infected woman. Potential teratogenic effect of antiretroviral drugs. 96
Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients 95
MEL-P, a GM-CSF-producing human melanoma cell line 95
Soluble HLA antigens: new roles and uses 94
Paralytic ileus and liver failure-an unusual presentation of advanced erythropoietic protoporphyria 94
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia Areata. 94
Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation. 94
Emerging biologic drugs for the treatment of rheumatoid arthritis 93
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 92
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers 92
Gastroesophageal reflux and lung disease in systemic sclerosis. 91
The role of AIRE polymorphisms in melanoma. 91
Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution. 91
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 91
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 90
Assessment of safety and the immune response to the CD4 "internal antigen" mouse anti-idiotypic Mab 16D7 in four patients with SLE. 88
The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer. 88
null 87
Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-γ production after sublingual immunotherapy in patients with allergic rhinitis 87
null 86
Assocition of -318C/T and +49A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of italian patients with systemic sclerosis 85
Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients 85
AIRE POLYMORPHISMS INDUCE VARIABLE EXTENT OF APOPTOSIS ON MELANOMA SPECIFIC CD8+T LYMPHOCYTES 84
Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus 82
IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules 81
Migraine during systemic lupus erythematosus: findings from brain single photon emission computed tomography 81
Level of HIV DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy 80
DECAY OF HIV-1 2LTR DNA IN INFECTED INDIVIDUALS AFTER THREE TO EIGHT YEARS OF SUSTAINED CONTROL OF VIREMIA. 79
Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones. 79
New aspects and perspectives in AIDS diagnosis 79
Virological markers in HIV-1 infected patients 79
Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. 75
Oxidative stress, apoptosis and immunological activation in acute myocardial infarction 74
EVALUATION OF HEPATIC FIBROSIS WITH TRANSIENT ELASTOGRAPHY (FIBROSCAN) AND APRI SCORE IN PATIENTS WITH SYSTEMIC SCLEROSIS AND ITS CORRELATION WITH PULMONARY, CARDIAC, RENAL AND ESOPHAGEAL INVOLVEMENT 74
Modifications of immunological and neuro-endocrine parameters induced by antiorthostatic bed-rest in human healthy volunteers. 74
Transforming growth factor-ß1 in supernatants from stored red blood cells inhibits neutrophil locomotion 72
Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis 72
null 72
null 71
Totale 10.575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.842
article - articoli 31.228
book - libri 365
conference - conferenze 1.369
curatela - curatele 0
other - altro 0
patent - brevetti 880
selected - selezionate 0
volume - volumi 0
Totale 67.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.592 0 0 0 0 286 358 487 204 251 530 375 101
2020/2021827 37 110 99 57 43 69 53 79 62 87 51 80
2021/20221.495 45 119 144 181 42 75 94 364 50 118 76 187
2022/20231.408 135 84 11 157 238 269 2 104 229 9 155 15
2023/2024611 22 103 5 67 36 117 42 46 38 12 38 85
2024/2025561 79 147 67 123 145 0 0 0 0 0 0 0
Totale 11.719